Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 26563384)

Published in J Am Soc Nephrol on November 12, 2015

Authors

Elizabeth L Yanik1, Christina A Clarke2, Jon J Snyder3, Ruth M Pfeiffer4, Eric A Engels4

Author Affiliations

1: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; elizabeth.yanik@nih.gov.
2: Cancer Prevention Institute of California, Fremont, California; Department of Health Research and Policy, Stanford University School of Medicine and Stanford Cancer Institute, Palo Alto, California;
3: Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, Minnesota; and Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota.
4: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland;

Articles cited by this

A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J Clin Oncol (2014) 9.86

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol (2008) 6.20

Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99

Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04

Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis (2002) 2.22

Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study. J Acquir Immune Defic Syndr (2001) 1.78

Risk of merkel cell carcinoma after solid organ transplantation. J Natl Cancer Inst (2015) 1.59

Circulating inflammation markers and prospective risk for lung cancer. J Natl Cancer Inst (2013) 1.59

Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. Am J Epidemiol (2013) 1.48

Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol (2013) 1.32

Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis (2013) 1.31

Cancer in end-stage renal disease: potential factors involved -editorial-. Am J Nephrol (1998) 1.28

Pulmonary infections and risk of lung cancer among persons with AIDS. J Acquir Immune Defic Syndr (2010) 1.25

Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood (2009) 1.23

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18

Renal cystic diseases and renal neoplasms: a mini-review. Clin J Am Soc Nephrol (2009) 1.10

Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study. Int J Cancer (2007) 1.06

Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev (2009) 1.05

Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study. BMC Nephrol (2012) 0.92

Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009. Am J Kidney Dis (2015) 0.92

Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev (2009) 0.92

Prospective pretransplant ultrasound screening in 206 patients for acquired renal cysts and renal cell carcinoma. Transplantation (1998) 0.87

Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy. AIDS (2013) 0.86

Cancer in patients on dialysis and after renal transplantation. Nephrol Dial Transplant (2008) 0.85

Excess of nevi related to immunodeficiency: a study in HIV-infected patients and renal transplant recipients. J Invest Dermatol (1996) 0.84

Development of adenocarcinoma and acquired cystic disease of the kidney in hemodialysis patients. Princess Takamatsu Symp (1987) 0.81

Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States. Am J Hematol (2014) 0.80